Form EFFECT GT Biopharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 20, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XRP Price Prediction: XRP, Ethereum, BNB or Remittix With Its $0.28 Entry and November Launch Catalyst?
- Doginal Dogs Announces DDMIAMI 2026 Schedule, Including an In-Person Card Championship
- The Boulder Group Arranges Sale of Net Leased Steak ’n Shake
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share